You are here » Home » Company » Natco Pharma Ltd

Natco Pharma Ltd.

BSE: 524816 Sector: Health care
NSE: NATCOPHARM ISIN Code: INE987B01026
BSE 00:00 | 17 May 719.10 18.75
(2.68%)
OPEN

695.20

HIGH

730.20

LOW

695.00

NSE 00:00 | 17 May 719.00 18.95
(2.71%)
OPEN

694.00

HIGH

725.90

LOW

694.00

OPEN 695.20
PREVIOUS CLOSE 700.35
VOLUME 10608
52-Week high 1188.95
52-Week low 645.45
P/E 50.96
Mkt Cap.(Rs cr) 13,127
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 695.20
CLOSE 700.35
VOLUME 10608
52-Week high 1188.95
52-Week low 645.45
P/E 50.96
Mkt Cap.(Rs cr) 13,127
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

About Natco Pharma Ltd.

Natco Pharma Ltd

Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company engaged in developing manufacturing and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). The company's focus is primarily on niche therapeutic areas and complex products. The company sells its products in over 40 countries. FDF products are sold in the United States I...> More

Natco Pharma Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   13,127
EPS - TTM () [*S] 14.11
P/E Ratio (X) [*S] 50.96
Face Value ()   2
Latest Dividend (%)   100.00
Latest Dividend Date 24 Feb 2022
Dividend Yield (%) 0.73
Book Value / Share () [*S] 229.69
P/B Ratio () [*S] 3.13
[*C] Consolidated     [*S] Standalone    

Natco Pharma Ltd - Financial Results

Particulars ( cr) Dec 2021 Dec 2020 % Chg
Net Sales 560.5 355.2 57.8
Other Income 30.2 30.8 -1.95
Total Income 590.7 386 53.03
Total Expenses 458.7 272.7 68.21
Operating Profit 132 113.3 16.5
Net Profit 80.4 63.4 26.81
Equity Capital 36.5 36.4 -
> More on Natco Pharma Ltd Financials Results

Natco Pharma Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Alembic Pharma 747.60 1.04 14694.08
Ajanta Pharma 1706.40 1.35 14572.66
Suven Pharma 516.30 1.71 13145.00
Natco Pharma 719.10 2.68 13127.17
J B Chem & Pharm 1617.60 -0.18 12504.05
Glenmark Pharma. 402.25 2.48 11351.49
ERIS Lifescience 697.55 1.27 9486.68
> More on Natco Pharma Ltd Peer Group

Natco Pharma Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 48.81
Banks/FIs 0.16
FIIs 11.97
Insurance 0.00
Mutual Funds 7.39
Indian Public 17.47
Custodians 0.00
Other 5.63
> More on Natco Pharma Ltd Share Holding Pattern

Natco Pharma Ltd - Research Reports

Date Broker Action Price Report
15/11/2021 Nirmal Bang Buy 830 PDF IconDetails
> More on Natco Pharma Ltd Research Reports

Natco Pharma Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week 2.86% 2.80% -0.09% 0.12%
1 Month -11.46% -11.39% -6.89% -6.96%
3 Month -18.56% -18.53% -6.17% -6.04%
6 Month -12.44% -12.46% -9.48% -9.16%
1 Year -21.88% -21.80% 9.56% 8.95%
3 Year 37.67% 38.00% 43.20% 42.54%

Natco Pharma Ltd - STOCK STRENGTH

Today's Low/High 695.00
730.20
Week Low/High 645.45
740.00
Month Low/High 645.45
827.00
YEAR Low/High 645.45
1189.00
All TIME Low/High 1.60
1189.00
.